Elevated IgG4 serum levels in patients with cystic fibrosis

PLoS One. 2017 Sep 18;12(9):e0181888. doi: 10.1371/journal.pone.0181888. eCollection 2017.

Abstract

Objective: Serum immunoglobulin (Ig) G4 elevation has been associated with several pathological conditions other than IgG4-related disease (IgG4-RD). In cystic fibrosis (CF), an elevation of specific IgG4 has been associated with colonization and infection by Pseudomonas aeruginosa. IgG4 elevation may be a marker of chronic infection or inflammatory stimulation. The aim of this study was to explore the prevalence of elevated IgG4 levels in CF and its correlation with the major clinical and microbiological features found in CF patients.

Methods: In a cross-sectional study, we analyzed data from a large cohort of adult CF patients attending the CF center of Lyon University Hospital. An elevated IgG4 level was defined as being above the cut-off value of 135 mg/dL.

Results: One hundred and sixty-five CF patients were analyzed. An IgG4 elevation was detected in 43 patients (26%). Compared with the control group (≤ 135 mg/dL), high IgG4 patients exhibited a greater prevalence of Staphylococcus aureus colonization and higher IgG, IgG1, IgG2 and IgE levels. No significant differences were observed in terms of pulmonary function, colonization with Pseudomonas aeruginosa, or the annual rate of bronchial exacerbations.

Conclusion: An elevated IgG4 serum level was frequently detected in adult CF patients and did not appear to be associated with poor lung function. We suggest that IgG4 elevation is a marker of the activation of tolerance. Its clinical significance remains to be demonstrated.

MeSH terms

  • Adult
  • Antibodies, Bacterial / blood*
  • Biomarkers / blood
  • Cohort Studies
  • Cystic Fibrosis / blood*
  • Cystic Fibrosis / microbiology
  • Female
  • Humans
  • Immunoglobulin G / blood*
  • Male
  • Pseudomonas Infections / blood*
  • Pseudomonas aeruginosa*
  • Staphylococcal Infections / blood
  • Staphylococcus aureus

Substances

  • Antibodies, Bacterial
  • Biomarkers
  • Immunoglobulin G

Grants and funding

The authors received no specific funding for this work.